Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis
- PMID: 38455071
- PMCID: PMC10918253
- DOI: 10.1016/j.jmh.2024.100217
Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis
Abstract
Background: Vaccine preventable diseases (VPDs) such as measles and rubella cause significant morbidity and mortality globally every year. The World Health Organization (WHO), reported vaccine coverage for both measles and rubella to be 71 % in 2019, indicating an immunity gap. Migrants in the EU/EEA may be at high risk of VPDs due to under-immunisation and poor living conditions. However, there are limited data on VPD seroprotection rates amongst migrants living in the United Kingdom (UK).
Methods: We conducted an exploratory cross-sectional serosurvey amongst a sample of adult migrants living in Leicester, UK to: (a) determine seroprotection rates for measles, varicella zoster, and rubella in this group; (b) identify risk factors associated with seronegativity and, (c) understand if self-reported vaccine or diseases history is an effective measure of seroprotection. Participants gave a blood sample and completed a questionnaire asking basic demographic details and vaccine and disease history for the three VPDs. We summarised the data using median and interquartile range (IQR) for non-parametric continuous variables and count and percentage for categorical variables. We used logistic regression to establish predictors of seroprotection against these diseases. We examined the reliability of self-reported vaccination/disease history for prediction of seroprotection through a concordance analysis.
Results: 149 migrants were included in the analysis. Seroprotection rates were: varicella zoster 98 %, rubella 92.6 % and measles 89.3 %. Increasing age was associated with seroprotection (OR 1.07 95 % CI 1.01-1.13 for each year increase in age). Migrants from Africa and the Middle East (aOR 15.16 95 % CI 1.31 - 175.06) and South/East Asia and Pacific regions (aOR 15.43 95 %CI 2.38 - 100.00) are significantly more likely to be seroprotected against measles as compared to migrants from Europe and Central Asia. The proportions of migrants unsure about their vaccination and disease history combined were 53.0 % for measles; 57.7 % for rubella; 43.0 % for varicella. There was no agreement between self-reported vaccination/disease history and serostatus.
Conclusion: Our findings suggest lower levels of seroprotection against measles in migrants living in Leicester, UK, with younger migrants and those from Europe and Central Asia more likely to lack seroprotection. A high proportion of surveyed migrants were unaware of their vaccination/disease history and self-reported vaccine/disease was a poor predictor of seroprotection against VPDs which is important for clinical decision-making regarding catch-up vaccination in this population. Our results, although derived from a small sample, suggest that there may be gaps in seroimmunity for certain VPDs in particular migrant populations. These findings should inform future qualitative studies investigating barriers to vaccine uptake in migrants and population-level seroprevalence studies aimed at determining individualised risk profiles based on demographic and migration factors.
Keywords: Measles; Migrant; Rubella; Seroprotection; Vaccination; Vaccine preventable diseases; Varicella.
© 2024 Published by Elsevier Ltd.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MP reports grants and personal fees from Gilead Sciences and personal fees from QIAGEN, outside the submitted work. MG, CAM, PWB, MJW, JG, KE, VR, AJL, and SH have no competing interest to declare.
Similar articles
-
An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.Transplant Cell Ther. 2021 Apr;27(4):317-326. doi: 10.1016/j.jtct.2021.01.017. Epub 2021 Jan 28. Transplant Cell Ther. 2021. PMID: 33836875
-
Seroprevalence of vaccine-preventable and non-vaccine-preventable infections in migrants in Spain.J Travel Med. 2021 Jun 1;28(4):taab025. doi: 10.1093/jtm/taab025. J Travel Med. 2021. PMID: 33611577
-
Seroprotection to vaccine-preventable diseases among workers at a Victorian tertiary hospital.Aust N Z J Public Health. 2016 Jun;40(3):284-9. doi: 10.1111/1753-6405.12508. Epub 2016 Mar 30. Aust N Z J Public Health. 2016. PMID: 27027875
-
Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review.Lancet Infect Dis. 2021 Dec;21(12):e387-e398. doi: 10.1016/S1473-3099(21)00193-6. Epub 2021 Oct 6. Lancet Infect Dis. 2021. PMID: 34626552
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
Cited by
-
Development and Evaluation of a New Measles Detection Assay Using Real-Time RT-PCR.Int J Mol Sci. 2025 Feb 20;26(5):1801. doi: 10.3390/ijms26051801. Int J Mol Sci. 2025. PMID: 40076428 Free PMC article.
-
Seroprevalence of Measles Antibodies Among Migrant Populations: A Systematic Review and Meta-Analysis.Cureus. 2024 Nov 22;16(11):e74243. doi: 10.7759/cureus.74243. eCollection 2024 Nov. Cureus. 2024. PMID: 39712819 Free PMC article. Review.
References
-
- Anichini G., Gandolfo C., Fabrizi S., Miceli G.B., Terrosi C., Gori Savellini G., Prathyumnan S., Orsi D., Battista G., Cusi M.G. Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy. Vaccines. 2020;8:66. doi: 10.3390/vaccines8010066. - DOI - PMC - PubMed
-
- Carter J., Mehrotra A., Knights F., et al. We don't routinely check vaccination background in adults”: a national qualitative study of barriers and facilitators to vaccine delivery and uptake in adult migrants through UK primary care. BMJ Open. 2022;12 doi: 10.1136/bmjopen-2022-062894. - DOI - PMC - PubMed
-
- Crawshaw A.F., Farah Y., Deal A., Rustage K., Hayward S.E., Carter J., Knights F., Goldsmith L.P., Campos-Matos I., Wurie F., Majeed A. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect. Dis. 2022 Sep 1. - PMC - PubMed
-
- Deal A., Halliday R., Crawshaw A.F., Hayward S.E., Burnard A., Rustage K., Carter J., Mehrotra A., Knights F., Campos-Matos I., Majeed A. Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review. Lancet Infect. Dis. 2021;21(12):e387–e398. Dec 1. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous